Suppliers / Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical

Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical

China Updated 9 July 2026

Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and one valid CEP across a filed portfolio of 5 molecules.

4
active US DMFs
1
valid CEPs
1
registered plants
1
filings across 1 regulators

Registered plants

Site FDA FEI
Suzhou City, China Not on file

What they file, and where

Molecule Regulators Docs
Degarelix US FDA 1
Linaclotide US FDA 1
Liraglutide US FDA 1
Octreotide EDQM 1
Semaglutide US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EDA (EG) 1 None

Comparing suppliers?

Choose your molecules and target markets. Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability